Bruker’s established IVDr-by-NMR solution for phenomics research is now also being offered for biobanking applications to assess sample quality with rigorous SOPs. It can provide reliable, quantitative data on 150 metabolic biomarkers in urine in a single experiment under full automation, with high throughput and at low cost per sample.
